Required Framework for the Collection of Real-life Data: An Example from University Eye Hospital Munich

被引:8
|
作者
Kortuem, Karsten [1 ,2 ]
Kern, Christoph [1 ]
Meyer, Gerhard [3 ]
Priglinger, Siegfried [1 ]
Hirneiss, Christoph [1 ]
机构
[1] LMU, Klinikum Univ Munchen, Augenklin, Mathildenstr 8, D-80336 Munich, Germany
[2] Moorfields Eye Hosp, Med Retina, London, England
[3] Klinikum Univ Munchen, Munich, Germany
关键词
information technology; legal; database; big data; machine learning; artificial intelligence; THERAPY; AMD;
D O I
10.1055/s-0043-115900
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background The importance of evaluating real-life data is constantly increasing. Currently available computer systems better allow for analyses of data, as more and more data is available in a digital form. Before a project for real-life data analyses is started, technical considerations and staff, legal, and data protection procedures need to be addressed. In this manuscript, experiences made at the University Eye Hospital in Munich will be shared. Materials and Methods Legal requirements, as found in laws and guidelines governing documentation and data privacy, are highlighted. Technical requirements for information technology infrastructure and software are defined. A survey conducted by the German Ophthalmological Society, among German eye hospitals investigating the current state of digitalization, was conducted. Also, staff requirements are outlined. Results A database comprising results of 330,801 patients was set up. It includes all diagnoses, procedures, clinical findings and results fromdiagnostic devices. This database was approved by the local data protection officer. In less than half of German eye hospitals (n = 21) that participated in the survey (n = 54), a complete electronic documentation is done. Fourteen institutions are completely paper-based, and the remainder of the hospitals used a mixed system. Conclusion In this work, we examined the framework that is required to develop a comprehensive database containing real-life data from clinics. In future, these databases will become increasingly important as more and more innovation are made in decision support systems. The base for this is comprehensive and well-curated databases.
引用
收藏
页码:1477 / 1482
页数:6
相关论文
共 50 条
  • [21] USE OF DROTECOGIN ALFA ACTIVATED IN REAL-LIFE: 6 SEARS EXPERIENCE IN A SPANISH UNIVERSITY HOSPITAL
    Molina Gonzalez, E.
    Piacentini, E.
    Sanchez, B.
    Romay, E.
    Nava, J. M.
    INTENSIVE CARE MEDICINE, 2011, 37 : S233 - S233
  • [22] Infections in primary Sjogren's syndrome patients: "Real-life" study of 109 patients from Montpellier university hospital
    Henrya, K.
    Delignyb, C.
    Viela, P. Witkowski Durand
    Morelc, J.
    Guilpaina, P.
    Goulabchandc, R.
    REVUE DE MEDECINE INTERNE, 2022, 43 (12): : 696 - 702
  • [23] Use of Oncotype DX ® testing in nodal positive breast cancer patients: Real-life data from a single center in Munich, Germany
    Kriegmair, A.
    Szeterlak, N.
    Schrodi, S.
    Stoetzer, O.
    Poelcher, M.
    Braun, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [24] Brolucizumab in patients with neovascular age-related macular degeneration: Real-life outcomes from a tertiary care eye hospital
    Fabozzi, Lorenzo
    Younis, Saad
    Sen, Sagnik
    Lopez-Cuenca, Ines
    Palmieri, Filomena
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 5) : S752 - S757
  • [25] Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece
    Tsentemeidou, A.
    Sotiriou, E.
    Vakirlis, E.
    Sideris, N.
    Papadimitriou, I.
    Lazaridou, E.
    Ioannides, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : E50 - E51
  • [26] Transbronchial cryobiopsies in a real-life setting: Results from a Dutch, nonacademic hospital
    Joosten, Roos
    Spanbroek, Michiel
    Janssen, Julius
    Vreuls, Willem
    Van Veen, Anneke
    Janssen, Rob
    Holters, Jurgen
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] Adherence to hymenoptera venom immunotherapy: Real-life data from Austria
    Fragner, M.
    Moser, J.
    Trautinger, F.
    Hafner, C.
    ALLERGY, 2020, 75 : 33 - 33
  • [28] Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
    Katerina Kopeckova
    Tomas Buchler
    Zbynek Bortlicek
    Karel Hejduk
    Renata Chloupkova
    Bohuslav Melichar
    Petra Pokorna
    Jiri Tomasek
    Zdenek Linke
    Lubos Petruzelka
    Igor Kiss
    Jana Prausova
    Targeted Oncology, 2017, 12 : 89 - 95
  • [29] Regorafenib in the real-life clinical practice: data from the czech registry
    Buchler, T.
    Bortlicek, Z.
    Hejduk, K.
    Melichar, B.
    Pokorna, P.
    Linke, Z.
    Petruzelka, L.
    Finek, J.
    Prausova, J.
    Kubackova, K.
    ANNALS OF ONCOLOGY, 2016, 27 : 45 - 45
  • [30] Defining successful NIV setup: data from a real-life cohort
    Jolly, Gregoire
    Fresnel, Emeline
    Caillard, Christian
    Gharsallaoui, Zouhair
    Cuvelier, Antoine
    Patout, Maxime
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58